Entecavir 0.5mg Tablets | ENTACOVER 0.5

Description

Entecavir IP 0.5mg Introduction to ENTACOVER 0.5 ENTACOVER 0.5 is a highly effective antiviral medication formulated with 0.5 mg of Entecavir IP, a potent inhibitor of hepatitis B virus (HBV) replication. This medication is primarily used to treat chronic hepatitis B in adults and children with active viral replication, ongoing liver inflammation, or significant liver damage. What is Entecavir IP? Entecavir IP, the active ingredient in ENTACOVER 0.5, is a nucleoside analogue that interferes with the viral DNA replication process, effectively reducing the virus's ability to multiply and spread. It's known for its high potency and selectivity against HBV. Indications and Usage Chronic Hepatitis B Treatment: ENTACOVER 0.5 is indicated for patients diagnosed with chronic hepatitis B virus infection with evidence of active viral replication, liver inflammation, or fibrosis. Long-Term Management: Often prescribed as part of long-term management plans to prevent hepatitis B virus complications, such as cirrhosis and liver cancer. Dosage and Administration Recommended Dosage: The usual dose for adults and children is 0.5 mg once daily on an empty stomach, at least 2 hours before or after a meal. Duration of Treatment: Treatment duration with ENTACOVER 0.5 varies based on the patient's virological response and clinical condition. Regular monitoring by a healthcare provider is essential. Benefits of Using ENTACOVER 0.5 High Efficacy: Demonstrates a strong ability to reduce HBV DNA levels in the blood. Lower Risk of Resistance: Particularly in patients who have not previously received antiviral treatment. Improved Liver Function: Helps improve liver function in patients with hepatitis B-related liver disease. Potential Side Effects While ENTACOVER 0.5 is generally well-tolerated, it may cause some side effects, including: Common Side Effects: Headache, fatigue, dizziness, and nausea. Serious Side Effects: Although rare, may include lactic acidosis and severe hepatomegaly with steatosis. Patient Considerations Monitoring Requirements: Regular liver function tests and monitoring for signs of lactic acidosis or liver enlargement. Drug Interactions: Care should be taken when combining ENTACOVER 0.5 with other medications, particularly those that affect kidney function or contribute to lactic acid production.